Some providers featured on this site may compensate us. This may affect the order and placement of listings but does not influence our editorial ratings or reviews.
TopWeightLoss.ioTreatmentsHub

Medvi vs HealthRx vs DirectMeds: Support, Speed, Simplicity

Last updated: Aug 16, 2026

We may earn a commission when you visit providers through links on this page - it never affects our rankings (how we stay objective). This content is for information only and is not medical advice - always consult a licensed clinician before starting treatment.

Here’s the short version

Three providers, three completely different bets. Medvi bets on people: video visits, dietician, coaching, and 14,372 Trustpilot reviews averaging 4.4. HealthRx bets on logistics: $99/month semaglutide (12-month prepaid, $1,188 at checkout) with overnight cold-chain delivery. DirectMeds bets on simplicity: one flat $147 for either medication, injections or needle-free sublingual drops, no membership. The matrix below puts the three bets side by side.

Medvi logo
14,372 reviews onTrustpilot

Summer Sale! up to $100 off

Visit Medvi
HealthRx logo
Licensed US telehealth

GLP-1 program from $99/month - clinician consult to overnight delivery

Visit HealthRx
DirectMeds logo
13,901 reviews onTrustpilot

Plans starting at just $147

Visit DirectMeds

Medvi vs HealthRx vs DirectMeds: side by side

Real published prices and terms - the differences that actually decide this matchup.

MedviHealthRxDirectMeds
Semaglutide$179/mo, all-inclusive$99/mo on a 12-month prepaid plan ($1,188 at checkout)$147/mo, flat at every dose
Tirzepatide$249/mo, all-inclusivefrom $179/mo$147/mo - same flat price
Billing & commitmentMonthly, all-inclusive - no surprise charges; HSA/FSA approved12-month prepaid - full year due at checkoutMonthly - no membership, cancel anytime
ShippingFree shippingFree overnight cold-chain, lot-trackedFree 1-2 day shipping
SupportVideo visits + free dietician & care coachingCare-team check-ins; clinician review on every requestDoctor-prescribed; injections or needle-free drops
Guarantee / refund-Free assessment - no payment to start-
Standout4.4 on Trustpilot across 14,372 reviewsLegitScript-certified (cert. 50087439); 503A pharmaciesOnly needle-free sublingual option in our ranking

Our verdict

Choose the bet that matches your bottleneck. If support determines your success, Medvi - its review record is the strongest evidence in this trio. If you've committed to a year and want the sharpest committed price with premium delivery, HealthRx. If you want one predictable number forever - or you need the needle-free format nobody else offers - DirectMeds. All three run licensed clinical review; none is a legitimacy risk.

Medvi vs HealthRx vs DirectMeds: FAQs

Which is cheapest: Medvi, HealthRx or DirectMeds?

For semaglutide: HealthRx at $99/month effective (12-month prepaid, $1,188 upfront), then DirectMeds at a flat $147/month, then Medvi at $179/month all-inclusive. For tirzepatide, DirectMeds' flat $147 leads, with HealthRx from $179 and Medvi at $249.

Which one has a needle-free option?

Only DirectMeds - it offers compounded GLP-1 as sublingual oral drops as well as weekly injections, at the same $147/month price. The prescribing doctor decides with you whether the drops format is appropriate.

Which delivers fastest?

HealthRx ships overnight in temperature-controlled, lot-tracked packaging - free on every plan. DirectMeds ships free in 1-2 days. Medvi includes free shipping on standard timelines.

Break it down two at a time

The head-to-head comparisons between these providers.

Sources & medical references

Treatment facts on this page are grounded in regulatory guidance and peer-reviewed research. Pricing and plan details come from each provider's published information.

  1. 1.Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial) - New England Journal of Medicine, 2021
  2. 2.Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1 trial) - New England Journal of Medicine, 2022
  3. 3.FDA Approves New Drug Treatment for Chronic Weight Management (semaglutide / Wegovy) - U.S. Food & Drug Administration, 2021
  4. 4.FDA Approves New Medication for Chronic Weight Management (tirzepatide / Zepbound) - U.S. Food & Drug Administration, 2023
  5. 5.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - U.S. Food & Drug Administration
  6. 6.Human Drug Compounding (503A pharmacy standards) - U.S. Food & Drug Administration
  7. 7.Semaglutide Injection - drug information - MedlinePlus, U.S. National Library of Medicine (NIH)